PRME compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

PRMEPrime Medicine, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

PRMEPrime Medicine, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

PRME

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±14.2%▼−4.22%×0.30

May 7 '26±15.5%▼−8.65%×0.56

Q1 FY26±18.4%▼−9.23%×0.50

Q3 FY25±17.6%▼−8.85%×0.50

AMGN

4 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±4.1%▲+4.57%×1.12

Q1 FY26±3.9%▼−4.75%×1.23

= impliedPRME realized, solidAMGN realized, hatchedOne scale, both sides: full bar = 19%× = |realized| ÷ impliedSource: market data

Feb 4 '26

±3.7%

▲+8.15%

×2.22

Q3 FY25±3.7%▲+7.81%×2.11

PRMEPrime Medicine, Inc.

4.44▼−6.04%· post 4.44

Mkt cap—Revenue$1MQ2 FY26Revenue$5MFY25

AMGNAmgen Inc

465.45▼−0.12%· post 466.36

ClosedNov 2 '26

Mkt cap$251.6BRevenue$10.1BQ2 FY26Revenue$36.8BFY25

Compare

ClosedNov 2 '26

PRMEPrime Medicine, Inc.

AMGNAmgen Inc

4.44▼−6.04%post 4.44

Price

465.45▼−0.12%post 466.36

—

Mkt cap

$251.6B

Q2 FY26$1M

Revenue

$10.1BQ2 FY26

FY25$5M

Revenue

$36.8BFY25

PRME4.44▼−6.04%vsAMGN465.45▼−0.12%ClosedNov 2 '26